More interestingly, the CD4 T cells from the HLA-DR.B1-matched donors are also able to kill the peptide-pulsed autologous DCs and more importantly, a tumor cell line, MDA-MB-231, expressing a high level of cyclin D1. The gene discussed is CCND1; the disease is neoplasm.